Cor­rect­ed: Ex­perts to de­cide with­in a year whether to rec­om­mend Duchenne mus­cu­lar dy­s­tro­phy for new­born screen­ing

An ad­vi­so­ry com­mit­tee has post­poned its de­ci­sion to de­cide whether Duchenne mus­cu­lar dy­s­tro­phy should be in­clud­ed in a fed­er­al­ly-rec­om­mend­ed new­born screen­ing pan­el for up to one year, Par­ent Project Mus­cu­lar Dy­s­tro­phy an­nounced Thurs­day.

The next ad­vi­so­ry com­mit­tees will con­vene Aug. 8 and 9, and Nov. 14 and 15.

Par­ent Project Mus­cu­lar Dy­s­tro­phy (PP­MD) — a Duchenne pa­tient ad­vo­ca­cy group — sub­mit­ted the nom­i­na­tion pack­age to add Duchenne mus­cu­lar dy­s­tro­phy to the Rec­om­mend­ed Uni­form Screen­ing Pan­el, or RUSP for short. The pan­el is a list of dis­or­ders that the US De­part­ment of Health and Hu­man Ser­vices rec­om­mends for new­born screen­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER